A critical discovery in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This essential malignant suppressor protein is frequently inactivated in many types of malignancies, https://socialinplace.com/story7459567/mini-antibodies-revive-the-p53-protein-a-new-approach-for-cancer-therapy